Trials / Completed
CompletedNCT00263159
Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
Pharmaceutical Care for Asthma Control Improvement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 221 (actual)
- Sponsor
- University Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
Detailed description
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pharmaceutical care for asthma patients |
Timeline
- Start date
- 2006-01-01
- Completion
- 2006-10-01
- First posted
- 2005-12-07
- Last updated
- 2007-12-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00263159. Inclusion in this directory is not an endorsement.